Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2013
Defining risks of taxane neuropathy: insights from randomized clinical trials
David Kudlowitz, Franco Muggia
Expert Opinion on Drug Safety
|
April 23, 2014
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications
David Kudlowitz, Franco Muggia
Anti-Cancer Drugs
|
December 5, 2013
Clinical features of taxane neuropathy
David Kudlowitz, Franco Muggia
Anti-Cancer Drugs
|
December 31, 2013
Novel taxanes
Franco Muggia, David Kudlowitz
Gynecologic Oncology Reports
|
September 14, 2018
Platinum type is key in determining degree of neuropathy
Franco Muggia, David Kudlowitz
Journal of Blood Medicine
|
December 8, 2015
Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test
Benjamin Y Lu, David Kudlowitz, Lawrence B Gardner
Diagnosis (Berlin, Germany)
|
December 9, 2021
Lessons in clinical reasoning ‒ pitfalls, myths and pearls: a case of recurrent pancreatitis
Vita Jaspan, Verity Schaye, Andrew S Parsons, et al.
Cancer Chemotherapy and Pharmacology
|
March 9, 2018
Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin
David Kudlowitz, Alejandro Velastegui, Fernanda Musa, et al.
Diagnosis (Berlin, Germany)
|
August 6, 2021
Hickam's dictum, Occam's razor, and Crabtree's bludgeon: a case of renal failure and a clavicular mass
Simone Blaser, Verity Schaye, John Hwang, et al.
Journal of Pediatric Hematology/Oncology
|
January 10, 2009
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report
Theodore Scott Nowicki, Kari Bjornard, David Kudlowitz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2013
Defining risks of taxane neuropathy: insights from randomized clinical trials
David Kudlowitz, Franco Muggia
Expert Opinion on Drug Safety
|
April 23, 2014
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications
David Kudlowitz, Franco Muggia
Anti-Cancer Drugs
|
December 5, 2013
Clinical features of taxane neuropathy
David Kudlowitz, Franco Muggia
Anti-Cancer Drugs
|
December 31, 2013
Novel taxanes
Franco Muggia, David Kudlowitz
Gynecologic Oncology Reports
|
September 14, 2018
Platinum type is key in determining degree of neuropathy
Franco Muggia, David Kudlowitz
Journal of Blood Medicine
|
December 8, 2015
Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA test
Benjamin Y Lu, David Kudlowitz, Lawrence B Gardner
Diagnosis (Berlin, Germany)
|
December 9, 2021
Lessons in clinical reasoning ‒ pitfalls, myths and pearls: a case of recurrent pancreatitis
Vita Jaspan, Verity Schaye, Andrew S Parsons, et al.
Cancer Chemotherapy and Pharmacology
|
March 9, 2018
Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin
David Kudlowitz, Alejandro Velastegui, Fernanda Musa, et al.
Diagnosis (Berlin, Germany)
|
August 6, 2021
Hickam's dictum, Occam's razor, and Crabtree's bludgeon: a case of renal failure and a clavicular mass
Simone Blaser, Verity Schaye, John Hwang, et al.
Journal of Pediatric Hematology/Oncology
|
January 10, 2009
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report
Theodore Scott Nowicki, Kari Bjornard, David Kudlowitz, et al.
Page
of 2